NCT06508827 2025-07-09Intravenous Iron in Combination With Standard of Care Immunotherapy in MelanomaIndiana UniversityPhase 2 Withdrawn
NCT00401544 2014-01-29Darbepoetin Alfa With or Without Intravenous (IV) IronAmgenPhase 2 Completed243 enrolled 26 charts